137
Views
0
CrossRef citations to date
0
Altmetric
Articles

Effect of lipopolysaccharide addition on the gene transfection of spermine-introduced pullulan-plasmid DNA complexes for human mesenchymal stem cells

, , &
Pages 1542-1558 | Received 09 May 2019, Accepted 27 Jul 2019, Published online: 08 Aug 2019

References

  • Slivac I, Guay D, Mangion M, et al. Non-viral nucleic acid delivery methods. Expert Opin Biol Therap. 2017;17:105–118.
  • Chira S, Jackson CS, Oprea I, et al. Progresses towards safe and efficient gene therapy vectors. Oncotarget. 2015;6:30675–30703.
  • Yin H, Kanasty RL, Eltoukhy AA, et al. Non-viral vectors for gene-based therapy. Nat Rev Genet. 2014;15:541–555.
  • Hill AB, Chen M, Chen CK, et al. Overcoming Gene-Delivery Hurdles: Physiological Considerations for Nonviral Vectors. Trends Biotechnol. 2016;34:91–105.
  • Li L, Wei Y, Gong C. Polymeric Nanocarriers for Non-Viral Gene Delivery. J Biomed Nanotechnol. 2015;11:739–770.
  • Del Pozo-Rodriguez A, Solinis MA, Rodriguez-Gascon A. Applications of lipid nanoparticles in gene therapy. Eur J Pharm Biopharm. 2016;109:184–193.
  • Wang X, Niu D, Hu C, et al. Polyethyleneimine-Based Nanocarriers for Gene Delivery. CPD. 2015;21:6140–6156.
  • Urbiola K, Blanco-Fernandez L, de Ilarduya CT. Nanoparticulated Polymeric Systems for Gene Delivery. CPD. 2015;21:4193–4200.
  • Xu H, Li Z, Si J. Nanocarriers in gene therapy: a review. J Biomed Nanotechnol. 2014;10:3483–3507.
  • Junquera E, Aicart E. Cationic lipids as transfecting agents of DNA in gene therapy. CTMC.. 2014;14:649–663.
  • Ibraheem D, Elaissari A, Fessi H. Gene therapy and DNA delivery systems. Int J Pharm. 2014;459:70–83.
  • Shcharbin D, Shakhbazau A, Bryszewska M. Poly(amidoamine) dendrimer complexes as a platform for gene delivery. Expert Opin Drug Deliv. 2013;10:1687–1698.
  • Wan Y, Moyle PM, Toth I. Endosome Escape Strategies for Improving the Efficacy of Oligonucleotide Delivery Systems. CMC. 2015;22:3326–3346.
  • Lam AP, Dean DA. Progress and prospects: nuclear import of nonviral vectors. Gene Ther.. 2010;17:439–447.
  • Saffari M, Moghimi HR, Dass CR. Barriers to Liposomal Gene Delivery: from Application Site to the Target. Iran J Pharm Res. 2016;15:3–17.
  • Ma D. Enhancing endosomal escape for nanoparticle mediated siRNA delivery. Nanoscale. 2014;6:6415–6425.
  • Pichon C, Billiet L, Midoux P. Chemical vectors for gene delivery: uptake and intracellular trafficking. Curr Opin Biotechnol. 2010;21:640–645.
  • Keeney M, Onyiah S, Zhang Z, et al. Modulating polymer chemistry to enhance non-viral gene delivery inside hydrogels with tunable matrix stiffness. Biomaterials. 2013;34:9657–9665.
  • Chu C, Kong H. Interplay of cell adhesion matrix stiffness and cell type for non-viral gene delivery. Acta Biomater.. 2012;8:2612–2619.
  • Kong HJ, Liu J, Riddle K, et al. Non-viral gene delivery regulated by stiffness of cell adhesion substrates. Nat Mater.. 2005;4:460–464.
  • Rea JC, Gibly RF, Davis NE, et al. Engineering surfaces for substrate-mediated gene delivery using recombinant proteins. Biomacromolecules. 2009;10:2779–2786.
  • Hattori Y, Maitani Y. DNA/Lipid complex incorporated with fibronectin to cell adhesion enhances transfection efficiency in prostate cancer cells and xenografts. Biol Pharm Bull. 2007;30:603–607.
  • Huang NC, Sieber M, Hsu SH. Correlating cell transfectability and motility on materials with different physico-chemical properties. Acta Biomater. 2015;28:55–63.
  • Pannier AK, Anderson BC, Shea LD. Substrate-mediated delivery from self-assembled monolayers: effect of surface ionization, hydrophilicity, and patterning. Acta Biomater. 2005;1:511–522.
  • Low WC, Rujitanaroj PO, Lee DK, et al. Mussel-Inspired Modification of Nanofibers for REST siRNA Delivery: Understanding the Effects of Gene-Silencing and Substrate Topography on Human Mesenchymal Stem Cell Neuronal Commitment. Macromol Biosci. 2015;15:1457–1468.
  • Adler AF, Leong KW. Emerging links between surface nanotechnology and endocytosis: impact on nonviral gene delivery. Nano Today. 2010;5:553–569.
  • Adler AF, Speidel AT, Christoforou N, et al. High-throughput screening of microscale pitted substrate topographies for enhanced nonviral transfection efficiency in primary human fibroblasts. Biomaterials. 2011;32:3611–3619.
  • Uchimura E, Yamada S, Nomura T, et al. Reverse transfection using antibodies against a cell surface antigen in mammalian adherent cell lines. J Biosci Bioeng. 2007;104:152–155.
  • Perlstein I, Connolly JM, Cui X, et al. DNA delivery from an intravascular stent with a denatured collagen-polylactic-polyglycolic acid-controlled release coating: mechanisms of enhanced transfection. Gene Ther. 2003;10:1420–1428.
  • Yoshikawa T, Uchimura E, Kishi M, et al. Transfection microarray of human mesenchymal stem cells and on-chip siRNA gene knockdown. J Controlled Release. 2004;96:227–232.
  • Bengali Z, Rea JC, Shea LD. Gene expression and internalization following vector adsorption to immobilized proteins: dependence on protein identity and density. J Gene Med. 2007;9:668–678.
  • Kopatz I, Remy JS, Behr JP. A model for non-viral gene delivery: through syndecan adhesion molecules and powered by actin. J Gene Med. 2004;6:769–776.
  • Garcia AJ. Get a grip: integrins in cell-biomaterial interactions. Biomaterials. 2005;26:7525–7529.
  • Okamura Y, Watari M, Jerud ES, et al. The extra domain A of fibronectin activates Toll-like receptor 4. J Biol Chem. 2001;276:10229–10233.
  • Wang ZJ, Zhang FM, Wang LS, et al. Lipopolysaccharides can protect mesenchymal stem cells (MSCs) from oxidative stress-induced apoptosis and enhance proliferation of MSCs via Toll-like receptor(TLR)-4 and PI3K/Akt. Cell Biol Int. 2009;33:665–674.
  • Hermanson GT. Bioconjugate techniques. London, UK: Academic Press; 1996.
  • Commerford SL. Iodination of nucleic acids in vitro. Biochemistry. 1971;10:1993–2000.
  • Janes KA, Calvo P, Alonso MJ. Polysaccharide colloidal particles as delivery systems for macromolecules. Adv Drug Deliv Rev. 2001;47:83–97.
  • Borchard G. Chitosans for gene delivery. Adv Drug Deliv Rev. 2001;52:145–150.
  • Ishii T, Okahata Y, Sato T. Mechanism of cell transfection with plasmid/chitosan complexes. Biochim Biophys Acta. 2001;1514:51–64.
  • Huang M, Fong CW, Khor E, et al. Transfection efficiency of chitosan vectors: Effect of polymer molecular weight and degree of deacetylation. J Control Release. 2005;106:391–406.
  • Guang Liu W, De Yao K. Chitosan and its derivatives-a promising non-viral vector for gene transfection . J Control Release. 2002;83:1–11.
  • Kim YH, Gihm SH, Park CR, et al. Structural characteristics of size-controlled self-aggregates of deoxycholic acid-modified chitosan and their application as a DNA delivery carrier. Bioconjugate Chem. 2001;12:932–938.
  • Lee KY, Kwon IC, Kim YH, et al. Preparation of chitosan self-aggregates as a gene delivery system. J Control Release. 1998;51:213–220.
  • Nagasaki T, Hojo M, Uno A, et al. Long-term expression with a cationic polymer derived from a natural polysaccharide: schizophyllan. Bioconjugate Chem. 2004;15:249–259.
  • Matsumoto T, Numata M, Anada T, et al. Chemically modified polysaccharide schizophyllan for antisense oligonucleotides delivery to enhance the cellular uptake efficiency. Biochim Biophys Acta. 2004;1670:91–104.
  • Azzam T, Eliyahu H, Shapira L, et al. Polysaccharide-oligoamine based conjugates for gene delivery. J Med Chem. 2002;45:1817–1824.
  • Azzam T, Raskin A, Makovitzki A, et al. Cationic polysaccharides for gene delivery. Macromolecules. 2002;35:9947–9953.
  • Azzam T, Eliyahu H, Makovitzki A, et al. Hydrophobized dextran-spermine conjugate as potential vector for in vitro gene transfection. J Control Release. 2004;96:309–323.
  • Jo J, Ikai T, Okazaki A, et al. Expression profile of plasmid DNA by spermine derivatives of pullulan with different extents of spermine introduced. J Control Release. 2007;118:389–398.
  • Jo J, Ikai T, Okazaki A, et al. Expression profile of plasmid DNA obtained using spermine derivatives of pullulan with different molecular weights. J Biomater Sci. 2007;18:883–899.
  • Li X, Jiang S, Tapping RI. Toll-like receptor signaling in cell proliferation and survival. Cytokine. 2010;49:1–9.
  • Kleveta G, Borzęcka K, Zdioruk M, et al. LPS induces phosphorylation of actin-regulatory proteins leading to actin reassembly and macrophage motility. J Cell Biochem. 2012;113:80–92.
  • van den Akker F, de Jager SC, Sluijter JP. Mesenchymal stem cell therapy for cardiac inflammation: immunomodulatory properties and the influence of toll-like receptors. Mediators Inflamm. 2013;2013:1.
  • Crisostomo PR, Wang Y, Markel TA, et al. Human mesenchymal stem cells stimulated by TNF-alpha, LPS, or hypoxia produce growth factors by an NF kappa B- but not JNK-dependent mechanism. Am J Physiol Cell Physiol. 2008;294:C675–682.
  • Ti D, Hao H, Tong C, et al. LPS-preconditioned mesenchymal stromal cells modify macrophage polarization for resolution of chronic inflammation via exosome-shuttled let-7b. J Transl Med. 2015;13:308.
  • He X, Wang H, Jin T, et al. TLR4 activation promotes bone marrow MSC proliferation and osteogenic differentiation via Wnt3a and Wnt5a signaling. PLoS One. 2016;11:e0149876.
  • Kim SH, Das A, Chai JC, et al. Transcriptome sequencing wide functional analysis of human mesenchymal stem cells in response to TLR4 ligand. Sci Rep. 2016;6:30311.
  • Herzmann N, Salamon A, Fiedler T, et al. Lipopolysaccharide induces proliferation and osteogenic differentiation of adipose-derived mesenchymal stromal cells in vitro via TLR4 activation. Exp Cell Res. 2017;350:115–122.
  • Lin T, Pajarinen J, Kohno Y, et al. Trained murine mesenchymal stem cells have anti-inflammatory effect on macrophages, but defective regulation on T-cell proliferation. FASEB J. 2019;33:4203–4211.
  • Lin T, Kohno Y, Huang JF, et al. Preconditioned or IL4-secreting mesenchymal stem cells enhanced osteogenesis at different stages. Tissue Eng Part A. 2019.
  • Hsiao CC, Chen PH, Cheng CI, et al. Toll-like receptor-4 is a target for suppression of proliferation and chemoresistance in HepG2 hepatoblastoma cells. Cancer Lett. 2015;368:144–152.
  • Stacey DW. Cyclin D1 serves as a cell cycle regulatory switch in actively proliferating cells. Curr Opin Cell Biol. 2003;15:158–163.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.